Functionally, TDO2 reversed the ability of miR-4738-3p to inhibit the mobility, migration, invasion, and proliferation of HCC cells (Fig. 4j, k, Supplementary Fig. S4f, g). The gene discussed is TDO2; the disease is hepatocellular carcinoma.